Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
2.730
-0.040 (-1.44%)
Oct 7, 2025, 4:00 PM EDT - Market closed

Orchestra BioMed Holdings Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
147152326112206262
Market Cap Growth
-21.01%-53.41%191.65%-45.72%-21.31%-
Enterprise Value
13087229193--
Last Close Price
2.734.009.139.9810.0812.81
PS Ratio
35.3257.64118.2431.67-263.6045.94
PB Ratio
499.314.614.802.13-10.4290.02
P/TBV Ratio
499.314.614.802.13--
EV/Sales Ratio
44.0732.9782.9654.51--
Debt / Equity Ratio
55.440.500.030.23-0.293.25
Asset Turnover
0.050.030.030.07--
Inventory Turnover
1.691.280.881.232.91-
Quick Ratio
1.994.137.824.520.902.50
Current Ratio
2.104.277.954.560.932.52
Return on Equity (ROE)
-313.82%-120.84%-81.47%-205.22%--
Return on Assets (ROA)
-77.32%-46.90%-33.75%-37.42%-52.79%-
Return on Capital (ROIC)
-143.16%-67.42%-48.00%-81.16%--
Earnings Yield
-47.32%-40.13%-15.05%-30.04%-11.16%-8.15%
FCF Yield
-40.53%-33.44%-14.16%-26.70%-9.56%-10.20%
Buyback Yield / Dilution
-7.26%-10.82%-121.67%-609.97%-4.86%-
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q